Renaissance Technologies LLC opened a $0.2M position in RAPPORT THERAPEUTICS INC
Renaissance Technologies LLC has added a new position worth $0.2 million in RAPPORT THERAPEUTICS INC, reflecting potential interest in the healthcare sector.
New Investment by Renaissance Technologies LLC
Renaissance Technologies LLC, led by renowned investor Jim Simons, has recently opened a new stock position in RAPPORT THERAPEUTICS INC. This marks the latest move in their dynamic investment strategy. The position is valued at $0.2 million, with Renaissance acquiring 15,600 shares of RAPP.
Significance and Sector Focus
RAPPORT THERAPEUTICS INC operates in the Healthcare sector, known for its innovative approach to treating rare diseases. This investment aligns with Renaissance's historical interest in biotechnology and pharmaceutical companies. While the portfolio percentage is listed as 0.00%, indicating a relatively small allocation, it underscores their strategic focus on high-potential opportunities.
Filing Details
The filing was made on August 13, 2025, and pertains to the period ending June 30, 2025. This move by Renaissance Technologies LLC highlights their ongoing evaluation of market opportunities, particularly within the healthcare sector.